AstraZeneca will now begin the Oxford University coronavirus vaccine's final trials. The United States government has contributed $1.2 billion or £910m to the research and development of the vaccine.
AstraZeneca denies it is in discussions to fast-track U.S. approval of its COVID-19 vaccine https://t.co/tH6rQKrDtd pic.twitter.com/7w7kvBRb76 — Samantha Petri (@PetriP30) August 24, 2020
Australia
Australian officials said that the country ordered enough doses for 25 million people. However, the exact amount of medicine was not disclosed.
China
Shenzhen Kangtai Biological Products, a Chinese company based in Shenzhen, has agreed on a deal with AstraZeneca to manufacture 100 million doses of the vaccine. By the end of 2021, the company will increase its capacity to 200 million doses every year.
For more news updates about AstraZeneca's COVID-19 vaccine, always keep your tabs open here at TechTimes.
Read also: Also Read: BEWARE: Extensive Use of Hand Sanitizers May Trigger Superbug 'Armageddon' -Expert Warns
This article is owned by TechTimes,
Written by: Giuliano de Leon.
